News List

Long-term anti-AIDS, Combination of two schemes submits application

On April 29, 2019,the anti-AIDS long-acting two-party “cabotegravir + Ripirilin”submitted to the FDA

For the initial treatment of HIV patients, the FDA approved the first dual-agent combination therapy

Today, the US FDA announced that it has approved the listing of the antiviral therapy Dovato (dolute

Novartis‘s Multiple sclerosis Innovative drug approved

Recently, US FDA announced approved the listing of Mayzent (siponimod) developed by Novartis, for th

Highly efficient trifluoromethylation and [18F]trifluoromethylation

Jichang Xiao, researcher at Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, ha

Redox neutral [4+1] cyclic reaction based on C-F fracture

Recently, Professor Feng Chao of the Institute of Advanced Synthesis of Nanjing University of Techno

FDA accelerates approval of no-limit cancer targeting therapy for the treatment of NTRK fusion tumors

Recently, LOXO Oncology and Bayer jointly announced that the FDA has accelerated the approval of a c

FDA approves new mechanism for listing new anti-influenza drugs

Today, the US FDA announced the approval of the new anti-influenza drug Xofluza (baloxavir marboxil)

FDA grants Relacorilant the qualification for orphan drugs for pancreatic cancer

Pancreatic cancer is the fourth leading cause of cancer-related deaths with a 5-year survival rate o

For the first time, scientists have discovered fluorine in natural conditions

Fluorine is the most reactive chemical element. That is why it is not found in nature in its element

Fluorinated antimalarial drug tafenoquine (Krintafel) approved by the US FDA

Recently, British pharmaceutical giant GlaxoSmithKline (GSK) announced that the fluorogenic anti-mal